Proposed amendments to the articles of association
Filed with HKEX · Stock code 1779 · · 3 pages · English
Summary by 6ix AI
LongBio Pharma (Suzhou) Co., Ltd. has proposed amendments to its Articles of Association to reflect changes in share capital and align with domestic laws. The amendments include updates to articles regarding registered capital and the structure of shares following a recent public offering. These proposed changes will be subject to shareholder approval at an upcoming extraordinary general meeting. The existing Articles of Association will remain valid until the proposed amendments are approved.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LongBio Pharma (Suzhou) Co., Ltd. on 6ix
Earlier from LongBio Pharma (Suzhou)
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim report
- Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
- Voluntary announcement a phase III clinical trial of LP-003 for the indication of seasonal AR met primary endpoints
Later from LongBio Pharma (Suzhou)
- Proposed amendments to the articles of association and notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Form of proxy for use by shareholders at the 2026 EGM (or any adjournment thereof) to be held at 4: 00 p.m. on Friday, October 30, 2026
- Voluntary announcement topline data from the phase ii clinical trial in china of LP-005 for the treatment of pnh
Follow LongBio Pharma (Suzhou) into a list and get an email when it puts out news.
Follow LongBio Pharma (Suzhou)